Melanocortin-3 receptor activates MAP kinase via PI3 kinase

被引:41
作者
Chai, Biaoxin [1 ]
Li, Ji-Yao [1 ]
Zhang, Weizhen [1 ]
Ammori, John B. [1 ]
Mulholland, Michael W. [1 ]
机构
[1] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
关键词
melanocortin-3; receptor; NDP-MSH; mitogen-activated protein kinase;
D O I
10.1016/j.regpep.2006.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HEK 293 cells stably expressing human melanocortin-3 receptor (MC3R) were exposed to melanocortin receptor agonist, NDP-MSH (10(-10)-10(-6) M). ERK1/2 was phosphorylated in a dose-dependent manner with an EC50, of 3.3 +/- 1.5 x 10(-9) M, similar to the IC50 of NDP-MSH binding to the MC3R. ERK1/2 phosphorylation was blocked by the melanocortin receptor antagonists SHU9119. NDP-MSH-induced ERKI/2 phosphorylation was sensitive to pertussis toxin and the PI3K inhibitor, wortmannin. Rp-cAMPS, BAPTA-AM and Myr-PKC did not inhibit the NDP-MSH-induced ERKI/2 phosphorylation. NDP-MSH stimulated cellular proliferation in a dose-dependent manner with a similar EC50 to ERKI/2 phosphorylation, 2.1 +/- 0.6 x 10(-9) M. Cellular proliferation was blocked by AGRP (86-132) and by the MEK inhibitor, PD98059. The NDP-MSH did not inhibit serum deprivation-induced apoptosis. MOR activation induces ERKI/2 phosphorylation via PI3K and this pathway is involved in cellular proliferation in HEK cells expressing MOR. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 38 条
  • [1] The melanocortin system and energy balance
    Butler, AA
    [J]. PEPTIDES, 2006, 27 (02) : 281 - 290
  • [2] Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase
    Chai, Biaoxin
    Li, Ji-Yao
    Zhang, Weizhen
    Newman, Erika
    Ammori, John
    Mulholland, Michael W.
    [J]. PEPTIDES, 2006, 27 (11) : 2846 - 2857
  • [3] Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
    Chen, AS
    Marsh, DJ
    Trumbauer, ME
    Frazier, EG
    Guan, XM
    Yu, H
    Rosenblum, CI
    Vongs, A
    Feng, Y
    Cao, LH
    Metzger, JM
    Strack, AM
    Camacho, RE
    Mellin, TN
    Nunes, CN
    Min, W
    Fisher, J
    Gopal-Truter, S
    MacIntyre, DE
    Chen, HY
    Van der Ploeg, LHT
    [J]. NATURE GENETICS, 2000, 26 (01) : 97 - 102
  • [4] Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction
    Chen, M
    Aprahamian, CJ
    Celik, A
    Georgeson, KE
    Garvey, WT
    Harmon, CM
    Yang, YK
    [J]. BIOCHEMISTRY, 2006, 45 (04) : 1128 - 1137
  • [5] Chhajlani V, 1996, BIOCHEM MOL BIOL INT, V38, P73
  • [6] Melanocortin receptor signaling kinase in vitro and through mitogen-activated protein in rat hypothalamus
    Daniels, D
    Patten, CS
    Roth, JD
    Yee, DK
    Fluharty, SJ
    [J]. BRAIN RESEARCH, 2003, 986 (1-2) : 1 - 11
  • [7] The melanocortin system
    Gantz, I
    Fong, TM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (03): : E468 - E474
  • [8] GANTZ I, 1993, J BIOL CHEM, V268, P8246
  • [9] Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides:: Studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor
    Getting, SJ
    Christian, HC
    Lam, CW
    Gavins, FNE
    Flower, RJ
    Schiöth, HB
    Perretti, M
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (06) : 3323 - 3330
  • [10] MC3 receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias
    Guarini, S
    Schiöth, HB
    Mioni, C
    Cainazzo, MM
    Ferrazza, G
    Giuliani, D
    Wikberg, JES
    Bertolini, A
    Bazzani, C
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 366 (02) : 177 - 182